The impact of obesity in managing diabetes

doi:10.5246/jcps.2015.06.053

Abstract

Abstract:

The epidemic of diabetes has been fueled by a parallel increase in the prevalence of overweight and obesity. Both diabetes and overweight/obesity have become major public health problems causing increased morbidity and mortality and are important risk factors for cardiovascular disease.Cardiovascular disease is the leading cause of death in China. Excess weight has been shown to be associated with increased prevalence of type 2 diabetes, hypertension, dyslipidemia, metabolic syndrome and certain cancers; while weight loss dramatically reduces these obesity-related diseases. Overweight and obesity are important modifiable risk factors for diabetes and cardiovascular disease. There has also been encouraging progress in treatments for obesity. In 2013, the American Medical Association declared obesity a “disease state”requiring a range of medical interventions to advance obesity treatment and prevention. Since 2012, four new drugs have been approved by the U.S. FDA for the treatment of obesity.

Key words: Obesity, Type 2 diabetes mellitus, Obesity treatment, Anti-obesity drugs

CLC Number:

R951

Supporting:

Xiaohui Xie, Fei Wang, Jiayu Cui. The impact of obesity in managing diabetes[J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(6): 412-418.

References

[1] Xu, Y.; Wang, L.; He, J.; Bi, Y.; Li, M.; Wang, T.; Wang, L.; Jiang, Y.; Dai, M.; Lu, J.; Xu, M.; Li, Y.; Hu, N.; Li, J.; Mi, S.; Chen, C.S.; Li, G.; Mu, Y.; Zhao, J.; Kong, L.; Chen, J.; Lai, S.; Wang, W.; Zhao, W.; Ning, G.; 2010 China Noncommunicable Disease Surveillance Group. JAMA. 2013, 310, 948–959.

[2] Pan, X.R.; Yang, W.Y.; Li, G.W.; Li, J. Diabetes Care. 1997, 20, 1664–1669.

[3] Yang, W.; Lu, J.; Weng, J.; Jia, W.; Ji, L.; Xiao, J.; Shan, Z.; Liu, J.; Tian, H.; Ji, Q.; Zhu, D.; Ge, J.; Lin, L.; Chen, L.; Guo, X.; Zhao, Z.; Li, Q.; Zhou, Z.; Shan, G.; He, J. N. Engl. J. Med. 2010, 362, 1090–1101.

[4] Hu, F.B. Diabetes Care. 2011, 34, 1249–1257.

[5] Yang, X.G.; Zhai, F.Y.; Piao, J.H.; Zhao, W.H.; He, Y.N.; Zhang, J. Chin. Prev. Med. 2010, 11, 5–7.

[6] Cui, Z.; Huxley, R.; Wu, Y.; Dibley, M.J. Int. J. Pediatr. Obes. 2010, 5, 365–374.

[7] Xi, B.; Liu, F.; Hao, Y.; Dong, H.; Mi, J. Int. J. Cardiol. 2014, http:dx.doi.org/10.1016.j.ijcard.2014.04.098

[8] Chan, J.C.; Zhang, Y.; Ning, G. Lancet Diabetes Endocrinol. 2014, http://dx.doi.org/10.1016/S2213–8587(14)70144–5

[9] Wang, H.; Zhai, F. Obes. Rev. 2013, 14, 134–140.

[10] AMA adopts new policies 2013. Available at http://www.ama–assn.org/ama/pub/news/news/2013/2013-06-18-new-ama-policies-annual-meeting.page. Accessed 11-23-14

[11] Jensen, M.D.; Ryan, D.H.; Apovian, C.M.; Ard, J.D.; Comuzzie, A.G.; Donato, K.A.; Hu, F.B.; Hubbard, V.S.; Jakicic, J.M.; Kushner, R.F.; Loria, C.M.; Millen, B.E.; Nonas, C.A.; Pi-Sunyer, F.X.; Stevens, J.; Stevens, V.J.; Wadden, T.A.; Wolfe, B.M.; Yanovski, S.Z.; Jordan, H.S.; Kendall, K.A.; Lux, L.J.; Mentor-Marcel, R.; Morgan, L.C.; Trisolini, M.G.; Wnek, J.; Anderson, J.L.; Halperin, J.L.; Albert, N.M.; Bozkurt, B.; Brindis, R.G.; Curtis, L.H.; DeMets, D.; Hochman, J.S.; Kovacs, R.J.; Ohman, E.M.; Pressler, S.J.; Sellke, F.W.; Shen, W.K.; Smith, S.C.Jr.; Tomaselli, G.F.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. Circulation. 2014, 129, S102–S138.

[12] National Institutes of Health. Obes. Res. 1998, 6, 51S–209S.

[13] American Diabetes Association. Standards of Medical Care in Diabetes-2015. Diabetes Care. 2015, 38, S1–S96.

[14] Li, S.; Xiao, J.; Ji, L.; Weng, J.; Jia, W.; Lu, J.; Zhou, Z.; Guo, X.; Liu, J.; Shan, Z.; Zhu, D.; Chen, L.; Zhao, Z.; Tian, H.; Ji, Q.; Ge, J.; Li, Q.; Lin, L.; Yang, Z.; He, J.; Yang, W. J. Diabetes Complications. , 28, 470–476.2014

[15] Katz, E.G.; Stevens, J.; Truesdale, K.P.; Cai, J.; North, K.E.; Steffen, L.M. Asia Pac. J. Clin. Nutr. 2013, 22, 626–634.

[16] Cornier, M.A.; Dabelea, D.; Hernandez, T.L.; Lindstrom, R.C.; Steig, A.J.; Stob, N.R.; Van Pelt, R.E.; Wang, H.; Eckel, R.H. Endocr. Rev. 2008, 29, 777–822.

[17] Zhou, B.F. Biomed Environ. Sci. 2002, 15, 83–96.

[18] Stern, D.; Smith, L.P.; Zhang, B.; Gordon-Larsen, P.; Popkin, B.M. Int. J. Obes. 2014. doi: 10.1038/ijo.2014.74.

[19] Li, G.; Chen, X.; Jang, Y.; Wang, J.; Xing, X.; Yang, W.; Hu, Y. Obes. Rev. 2002, 3, 167–172.

[20] Pan, X.R.; Li, G.W.; Hu, Y.H.; Wang, J.X.; Yang, W.Y.; An, Z.X.; Hu, Z.X.; Lin, J.; Xiao, J.Z.; Cao, H.B.; Liu, P.A.; Jiang, X.G.; Jiang, Y.Y.; Wang, J.P.; Zheng, H.; Zhang, H.; Bennett, P.H.; Howard, B.V. Diabetes Care. 1997, 20, 537–544.

[21] Knowler, W.C.; Barrett-Connor, E.; Fowler, S.E.; Hamman, R.F.; Lachin, J.M.; Walker, E.A.; Nathan, D.M.; Diabetes Prevention Program Research Group. N. Engl. J. Med. 2002, 346, 393–403.

[22] Tuomilehto, J.; Lindström, J.; Eriksson, J.G.; Valle, T.T.; Hämäläinen, H.; Ilanne-Parikka, P.; Keinänen-Kiukaanniemi, S.; Laakso, M.; Louheranta, A.; Rastas, M.; Salminen, V.; Uusitupa, M.; Finnish Diabetes Prevention Study Group. N. Engl. J. Med. 2001, 344, 1343–1350.

[23] Li, G.; Zhang, P.; Wang, J.; Gregg, E.W.; Yang, W.; Gong, Q.; Li, H.; Li, H.; Jiang, Y.; An, Y.; Shuai, Y.; Zhang, B.; Zhang, J.; Thompson, T.J.; Gerzoff, R.B.; Roglic, G.; Hu, Y.; Bennett, P.H. Lancet. 2008, 371, 1783–1789.

[24] Lindström, J.; Ilanne-Parikka, P.; Peltonen, M.; Aunola, S.; Eriksson, J.G.; Hemiö, K.; Hämäläinen, H.; Härkönen, P.; Keinänen-Kiukaanniemi, S.; Laakso, M.; Louheranta, A.; Mannelin, M.; Paturi, M.; Sundvall, J.; Valle, T.T.; Uusitupa, M.; Tuomilehto, J.; Finnish Diabetes Prevention Study Group. Lancet. 2006, 368, 1673–1679.

[25] Diabetes Prevention Program Research Group; Knowler, W.C.; Fowler, S.E.; Hamman, R.F.; Christophi, C.A.; Hoffman, H.J.; Brenneman, A.T.; Brown-Friday, J.O.; Goldberg, R; Venditti, E; Nathan, D.M. Lancet. 2009, 374, 1677–1686.

[26] Chiasson, J.L.; Josse, R.G.; Gomis, R.; Hanefeld, M.; Karasik, A.; Laakso, M.; STOP-NIDDM Trail Research Group. Lancet. 2002, 359, 2072–2077.

[27] DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators; Gerstein, H.C.; Yusuf, S.; Bosch, J.; Pogue, J.; Sheridan, P.; Dinccag, N.; Hanefeld, M.; Hoogwerf, B.; Laakso, M.; Mohan, V.; Shaw, J.; Zinman, B.; Holman, R.R. Lancet. 2006, 368, 1096–1105.

[28] Diabetes Prevention Program Research Group. Diabetes Care. 2012, 35, 723–730.

[29] Wing, R.R.; Look AHEAD Research Group. Diabetes Obes. Metab. 2014, 16, 1183–1191.

[30] Yanovski, S.Z.; Yanovski, J.A. JAMA. 2014, 311, 74–86.

[31] Connolly, H.M.; Crary, J.L.; McGoon, M.D.; Hensrud, D.D.; Edwards, B.S.; Edwards, W.D.; Schaff, H.V. N. Engl. J. Med. 1997, 337, 581–588.

[32] James, W.P.; Caterson, I.D.; Coutinho, W.; Finer, N.; Van Gaal, L.F.; Maggioni, A.P.; Torp-Pedersen, C.; Sharma, A.M.; Shepherd, G.M.; Rode, R.A.; Renz, C.L. N. Engl. J. Med. 2010, 363, 905–917.

[33] Norris, S.L.; Zhang, X.; Avenell, A.; Gregg, E.; Schmid, C.H.; Lau, J. Cochrane Database Syst. Rev. 2005, 1, CD004096.

[34] Smith, S.R.; Weissman, N.J.; Anderson, C.M.; Sanchez, M.; Chuang, E.; Stubbe, S.; Bays, H.; Shanahan, W.R. N. Engl. J. Med. 2010, 363, 245–256.

[35] Fidler, M.C.; Sanchez, M.; Raether, B.; Weissman, N.J.; Smith, S.R.; Shanahan, W.R.; Anderson, C.M. J. Clin. Endocrinol. Metab. 2011, 96, 3067–3077.

[36] O’Neil, P.M.; Smith, S.R.; Weissman, N.J.; Fidler, M.C.; Sanchez, M.; Zhang, J.; Raether, B.; Anderson, C.M.; Shanahan, W.R. Obesity (Silver Spring). 2012, 20, 1426–1436.

[37] Allison, D.B.; Gadde, K.M.; Garvey, W.T.; Peterson, C.A.; Schwiers, M.L.; Najarian, T.; Tam, P.Y.; Troupin, B.; Day, W.W. Obesity (Silver Spring). 2012, 20, 330–342.

[38] Gadde, K.M.; Allison, D.B.; Ryan, D.H.; Peterson, C.A.; Troupin, B.; Schwiers, M.L.; Day, W.W. Lancet. 2011, 377, 1341–1352.

[39] FDA approves weight-management drug Contrave. http://www.fda.gov/NewsEvents/Newsroom/Press Announcements/ucm413896.htm . Accessed 11-23-14.

[40] FDA approves weight-management drug Saxenda. http://www.fda.gov/NewsEvents/Newsroom/Press Announcements/ucm427913.htm. Accessed 12-29-2014.

[41] Schauer, P.R.; Kashyap, S.R.; Wolski, K.; Brethauer, S.A.; Kirwan, J.P.; Pothier, C.E.; Thomas, S.; Abood, B.; Nissen, S.E.; Bhatt, D.L. N. Engl. J. Med. 2012, 366, 1567–1576.

[42] Sjöström, L.; Narbro, K.; Sjöström, C.D.; Karason, K.; Larsson, B.; Wedel, H.; Lystig, T.; Sullivan, M.; Bouchard, C.; Carlsson, B.; Bengtsson, C.; Dahlgren, S.; Gummesson, A.; Jacobson, P.; Karlsson, J.; Lindroos, A.K.; Lönroth, H.; Näslund, I.; Olbers, T.; Stenlöf, K.; Torgerson, J.; Agren, G.; Carlsson, L.M. N. Engl. J. Med. 2007, 357, 741-752.

[43] Adams, T.D.; Gress, R.E.; Smith, S.C.; Halverson, R.C.; Simper, S.C.; Rosamond, W.D.; Lamonte, M.J.; Stroup, A.M.; Hunt, S.C. N. Engl. J. Med. 2007, 357, 753-761.